Manufacturing

Siegfried Schmitt, PhD, is Vice President Technical at Parexel International, Siegfried.Schmitt@parexel.com.

Articles

There are no two completely identical freeze dryer units in operation anywhere.

The Freeze Drying Challenge

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

GlaxoSmithKline and Daiichi Sankyo have formed a joint venture that they claim will create the biggest vaccines company in Japan. The joint venture will seek to improve access to vaccinations in the Asian nation as well as introduce new vaccines.

GSK and Daiichi Sankyo Launch Vaccine Venture in Japan

Angie Drakulich was editorial director of Pharmaceutical Technology.

The standardization of upstream and downstream bioprocessing is growing, but several kinks need to be ironed out.

Platform Technologies

Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.

Sustainable Investment

We bring industry experts together to discuss the importance of self-administration and what injection technologies are best suited to this cause.

Pointed Debate: Expert Views on Injectables

Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries. Pneumococcal disease can lead to pneumonia, meningitis, and sepsis, and is one of leading causes of death in children under the age of five in developing countries.

Pfizer, GSK Commit to Supplying Developing World with Vaccines

Pfizer and GlaxoSmithKline have announced separate agreements with the GAVI Alliance to supply pneumococcal vaccines to developing countries.

Pfizer, GSK commit supplying developing world with vaccines

Last week, the US Department of Health and Human Services and Novartis Vaccines and Diagnostics dedicated a manufacturing plant that can create influenza vaccine using cultured animal cells instead of the conventional expression system of fertilized eggs.

HHS and Novartis Dedicate First Cell-Based Flu Vaccine Plant in US

EMA released two concept papers for consultation that address the need to revise existing guidelines on biosimilar medicines and influenza vaccines.

EMA Invites Feedback on Biosimilar and Vaccine Concept Papers

Amy Ritter was Scientific Editor, BioPharm International.

Single-use components in the fill–finish line provides increased flexibility to multiproduct manufacturers.

Manufacturing, Biologic Drugs